August 27, 2016 3:23 AM ET

Life Sciences Tools and Services

Company Overview of Rubicon Genomics, Inc.

Company Overview

Rubicon Genomics, Inc. engages in the development and commercialization of sample-specific nucleic acid library preparation products for use in research and clinical testing on next-generation sequencing (NGS), microarray, and q-PCR platforms. The company creates molecular biology tools for genetic, epigenetic, and expression analysis of various samples to facilitate gene-based research, drug development, and diagnostics. Its products include ThruPLEX DNA-seq kits to generate DNA libraries with expanded multiplexing capability and diversity with lower duplication rates; PicoPLEX DNA-seq kits to streamline library preparation and PicoPLEX process used by IVF clinics for pre-implantation genet...

4743 Venture Drive

Ann Arbor, MI 48108

United States

Founded in 2000





Key Executives for Rubicon Genomics, Inc.

Chairman, Chief Executive Officer and President
Age: 67
Co-Founder and Chief Scientific Officer
Chief Financial Officer
Chief Operating Officer
Vice President of Business Development
Compensation as of Fiscal Year 2016.

Rubicon Genomics, Inc. Key Developments

Rubicon Genomics, Inc. Provides Sales Guidance for 2016

Rubicon Genomics, Inc. provided sales guidance for 2016. The company expects to post sales gains of greater than 40% in 2016.

Rubicon Genomics, Inc Announces Distribution Agreement with Beckman Coulter Life Sciences for its ThruPLEX Plasma-Seq Kits

Rubicon Genomics, Inc. announced a new agreement with Beckman Coulter Life Sciences for distribution of its ThruPLEX Plasmaseq kits for research applications. ThruPLEX Plasmaseq prepares DNA nextgeneration sequencing (NGS) libraries for the analysis of cellfree DNA circulating in plasma. The nonexclusive agreement covers the U.S. and Canada. It follows an announcement last fall that the ThruPLEX Plasmaseq kit has been automated for use with Beckman Coulter's Biomek FXP Automated Workstation, a leading automated liquid handling solution for laboratories worldwide. ThruPLEX Plasmaseq kits enable liquid biopsies for research applications in cancer and other conditions by producing highly reproducible libraries for Illumina instruments from small amounts of cellfree DNA in plasma (from less than 1 ng up to 30 ng of cell free DNA.) Its optimized repair and ligation chemistries and a modified protocol provide high library diversity at low input amounts with broad and consistent GC coverage. ThruPLEX Plasmaseq libraries are suitable for whole genome, whole exome and targeted gene sequencing. The performance of the ThruPLEX Plasmaseq kit has been validated by researchers at the Karolinska Institute in Sweden and Cancer Research UK (CRUK) in Cambridge, UK.

Rubicon Genomics, Inc. Adds Delonix Healthcare Pvt. Ltd and Biocena Ltd. as New Distributors

Rubicon Genomics, Inc. announced the addition of new distributors in India and Poland. The new distributors are Delonix Healthcare Pvt. Ltd. and Biocena Ltd.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Rubicon Genomics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at